ACTEMRA - tocilizumab
Navigation: NDC > Supplier starting with: G > GENENTECH, INC.| Field | Value |
|---|---|
| NDC Code: | 50242-135 |
| Proprietary Name: | ACTEMRA |
| Suffix: | |
| Non-Proprietary Name: | tocilizumab |
| Dosage Form: | INJECTION, SOLUTION, CONCENTRATE |
| Method: | INTRAVENOUS |
| Original Marketing Date: | 08-01-2010 |
| Category Name: | BLA |
| Application Number: | BLA125276 |
| Labeler: | GENENTECH, INC. |
| Substance Name: | TOCILIZUMAB |
| Active Numerator Strength: | 20 |
| Active Ingredient Unit: | mg/mL |
| Pharm Classes: | |
| DEA Schedule: |